The impact of specific mutations in TP53 gene on the results of alemtuzumab therapy in chronic lymphocytic leukemia patients

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

DOUBEK Michael MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona PANOVSKÁ Anna KOZMON Petr DOBEŠ Petr VAŇKOVÁ Gabriela ŠMARDOVÁ Jana KUGLÍK Petr MRÁZ Marek TICHÝ Boris ŠEBEJOVÁ Ludmila MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka

Year of publication 2011
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info